Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kerstin Cornils is active.

Publication


Featured researches published by Kerstin Cornils.


Nature Medicine | 2011

RGB marking facilitates multicolor clonal cell tracking

Kristoffer Weber; Michael Thomaschewski; Michael Warlich; T. Volz; Kerstin Cornils; Birte Niebuhr; Maike Täger; M. Lütgehetmann; J M. Pollok; Carol Stocking; M. Dandri; Daniel Benten; Boris Fehse

We simultaneously transduced cells with three lentiviral gene ontology (LeGO) vectors encoding red, green or blue fluorescent proteins. Individual cells were thereby marked by different combinations of inserted vectors, resulting in the generation of numerous mixed colors, a principle we named red-green-blue (RGB) marking. We show that lentiviral vector–mediated RGB marking remained stable after cell division, thus facilitating the analysis of clonal cell fates in vitro and in vivo. Particularly, we provide evidence that RGB marking allows assessment of clonality after regeneration of injured livers by transplanted primary hepatocytes. We also used RGB vectors to mark hematopoietic stem/progenitor cells that generated colored spleen colonies. Finally, based on limiting-dilution and serial transplantation assays with tumor cells, we found that clonal tumor cells retained their specific color-code over extensive periods of time. We conclude that RGB marking represents a useful tool for cell clonality studies in tissue regeneration and pathology.


PLOS ONE | 2011

Radiation Rescue: Mesenchymal Stromal Cells Protect from Lethal Irradiation

Claudia Lange; Bärbel Brunswig-Spickenheier; Heike Cappallo-Obermann; Katharina Eggert; Ursula M. Gehling; Cornelia Rudolph; Brigitte Schlegelberger; Kerstin Cornils; Jozef Zustin; Andrej Spiess; Axel R. Zander

Background Successful treatment of acute radiation syndromes relies on immediate supportive care. In patients with limited hematopoietic recovery potential, hematopoietic stem cell (HSC) transplantation is the only curative treatment option. Because of time consuming donor search and uncertain outcome we propose MSC treatment as an alternative treatment for severely radiation-affected individuals. Methods and Findings Mouse mesenchymal stromal cells (mMSCs) were expanded from bone marrow, retrovirally labeled with eGFP (bulk cultures) and cloned. Bulk and five selected clonal mMSCs populations were characterized in vitro for their multilineage differentiation potential and phenotype showing no contamination with hematopoietic cells. Lethally irradiated recipients were i.v. transplanted with bulk or clonal mMSCs. We found a long-term survival of recipients with fast hematopoietic recovery after the transplantation of MSCs exclusively without support by HSCs. Quantitative PCR based chimerism analysis detected eGFP-positive donor cells in peripheral blood immediately after injection and in lungs within 24 hours. However, no donor cells in any investigated tissue remained long-term. Despite the rapidly disappearing donor cells, microarray and quantitative RT-PCR gene expression analysis in the bone marrow of MSC-transplanted animals displayed enhanced regenerative features characterized by (i) decreased proinflammatory, ECM formation and adhesion properties and (ii) boosted anti-inflammation, detoxification, cell cycle and anti-oxidative stress control as compared to HSC-transplanted animals. Conclusions Our data revealed that systemically administered MSCs provoke a protective mechanism counteracting the inflammatory events and also supporting detoxification and stress management after radiation exposure. Further our results suggest that MSCs, their release of trophic factors and their HSC-niche modulating activity rescue endogenous hematopoiesis thereby serving as fast and effective first-line treatment to combat radiation-induced hematopoietic failure.


Journal of Cell Biology | 2011

Control of bone formation by the serpentine receptor Frizzled-9.

Joachim Albers; Jochen Schulze; F. Timo Beil; Matthias Gebauer; Anke Baranowsky; Johannes Keller; Robert P. Marshall; Kristofer Wintges; Felix W. Friedrich; Matthias Priemel; Arndt F. Schilling; Johannes M. Rueger; Kerstin Cornils; Boris Fehse; Thomas Streichert; Guido Sauter; Franz Jakob; Karl L. Insogna; Barbara R. Pober; Klaus-Peter Knobeloch; Uta Francke; Michael Amling; Thorsten Schinke

Fzd9, induced upon osteoblast differentiation, is required for bone matrix mineralization in primary osteoblasts.


Molecular Therapy | 2009

Stem Cell Marking With Promotor-deprived Self-inactivating Retroviral Vectors Does Not Lead to Induced Clonal Imbalance

Kerstin Cornils; Claudia Lange; Axel Schambach; Martijn H. Brugman; Regine Nowak; Michael Lioznov; Christopher Baum; Boris Fehse

Stable genetic modification of stem cells holds great promise for gene therapy and marking, but commonly used gamma-retroviral vectors were found to influence growth/survival characteristics of hematopoietic stem cells (HSCs) by insertional mutagenesis. In this article, we show that promoter-deprived gamma-retroviral self-inactivating (pd-SIN) vectors allow stable genetic marking of serially reconstituting murine HSC. In contrast to findings with gamma-retroviral long terminal repeat (LTR) vectors, serial transplantation of pd-SIN-marked HSC in a sensitive mouse model was apparently not associated with induced clonal imbalance of gene-marked HSC. Furthermore, insertions of pd-SIN into protooncogenes, growth-promoting and signaling genes occurred significantly less frequent than in control experiments with LTR vectors. Also, transcriptional dysregulation of neighboring genes potentially caused by the pd-SIN insertion was rarely seen and comparatively weak. The integration pattern of promotor-deprived SIN vectors in reconstituting HSC seems to depend on the transcriptional activity of the respective gene loci reflecting the picture described for LTR vectors. In conclusion, our data strongly support the use of SIN vectors for gene-marking studies and suggest an increased therapeutic index for vectors lacking enhancers active in HSC.


Nucleic Acids Research | 2014

Multiplexing clonality: combining RGB marking and genetic barcoding

Kerstin Cornils; Lars Thielecke; Svenja Hüser; Michael Forgber; Michael Thomaschewski; Nadja Kleist; Kais Hussein; Kristoffer Riecken; T. Volz; Sebastian Gerdes; Ingmar Glauche; Andreas Dahl; M. Dandri; Ingo Roeder; Boris Fehse

RGB marking and DNA barcoding are two cutting-edge technologies in the field of clonal cell marking. To combine the virtues of both approaches, we equipped LeGO vectors encoding red, green or blue fluorescent proteins with complex DNA barcodes carrying color-specific signatures. For these vectors, we generated highly complex plasmid libraries that were used for the production of barcoded lentiviral vector particles. In proof-of-principle experiments, we used barcoded vectors for RGB marking of cell lines and primary murine hepatocytes. We applied single-cell polymerase chain reaction to decipher barcode signatures of individual RGB-marked cells expressing defined color hues. This enabled us to prove clonal identity of cells with one and the same RGB color. Also, we made use of barcoded vectors to investigate clonal development of leukemia induced by ectopic oncogene expression in murine hematopoietic cells. In conclusion, by combining RGB marking and DNA barcoding, we have established a novel technique for the unambiguous genetic marking of individual cells in the context of normal regeneration as well as malignant outgrowth. Moreover, the introduction of color-specific signatures in barcodes will facilitate studies on the impact of different variables (e.g. vector type, transgenes, culture conditions) in the context of competitive repopulation studies.


Developmental Dynamics | 2006

Dynamic expression of LIM cofactors in the developing mouse neural tube

Heather P. Ostendorff; Baris Tursun; Kerstin Cornils; Anne Schlüter; Alexander Drung; Cenap Güngör; Ingolf Bach

The developmental regulation of LIM homeodomain transcription factors (LIM‐HD) by the LIM domain‐binding cofactors CLIM/Ldb/NLI and RLIM has been demonstrated. Whereas CLIM cofactors are thought to be required for at least some of the in vivo functions of LIM‐HD proteins, the ubiquitin ligase RLIM functions as a negative regulator by its ability to target CLIM cofactors for proteasomal degradation. In this report, we have investigated and compared the protein expression of both factors in the developing mouse neural tube. We co‐localize both proteins in many tissues and, although widely expressed, we detect high levels of both cofactors in specific neural tube regions, e.g., in the ventral neural tube, where motor neurons reside. The mostly ubiquitous distribution of RLIM‐ and CLIM‐encoding mRNA differs from the more specific expression of both cofactors at the protein level, indicating post‐transcriptional regulation. Furthermore, we show that both cofactors not only co‐localize with each other but also with Isl and Lhx3 LIM‐HD proteins in developing ventral neural tube neurons. Our results demonstrate the dynamic expression of cofactors participating in the regulation of LIM‐HD proteins during the development of the neural tube in mice and suggest additional post‐transcriptional regulation in the nuclear LIM‐HD protein network. Developmental Dynamics 235:786–791, 2006.


Experimental Hematology | 2013

Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector

Kerstin Cornils; Cynthia C. Bartholomae; Lars Thielecke; Claudia Lange; Anne Arens; Ingmar Glauche; Ulrike Mock; Kristoffer Riecken; Sebastian Gerdes; Christof von Kalle; Manfred Schmidt; Ingo Roeder; Boris Fehse

Retroviral gene marking has been used successfully in preclinical and clinical transplantation settings. Highly sensitive techniques for vector insertion-site determination, such as linear amplification-mediated polymerase chain reaction (LAM-PCR) in conjunction with next-generation sequencing, have been introduced to assess the composition of gene-marked hematopoiesis at a single-cell level. Here we used these novel techniques for directly comparing clonal reconstitution kinetics in mice transplanted with bone-marrow-derived stem cells genetically marked with either a standard, spleen focus-forming virus long terminal repeat (LTR)-driven γ-retroviral, or a lentiviral self-inactivating vector containing an identical but internal spleen focus-forming virus-derived enhancer/promoter. We observed that the use of the lentiviral self-inactivating vector for gene marking was associated with a broader repertoire of differently marked hematopoietic clones. More importantly, we found a significantly higher probability of insertions in growth-promoting, clonal-dominance-associated genes in the spleen focus-forming virus LTR-driven γ-retroviral vector at later time points of analysis. Based on our data, we suggest that the combined use of LAM-PCR and next-generation sequencing represents a potent tool for the analysis of clonal reconstitution kinetics in the context of gene marking with integrated vectors. At the same time, our findings prove that the use of multiple restriction enzymes for LAM-PCR is indispensable to detect most or ideally all individual stem cell clones contributing to hematopoiesis. We have also found that techniques such as quantitative PCR can be helpful to retrospectively analyze reconstitution kinetics for individual hematopoietic stem cell clones. Finally, our results confirm the notion that marking with lentiviral self-inactivating vectors is associated with a lower risk of genotoxicity as compared with γ-retroviral LTR vectors.


FEBS Journal | 2007

Modulation of Ca2+ entry and plasma membrane potential by human TRPM4b

Ralf Fliegert; Günter Glassmeier; Frederike Schmid; Kerstin Cornils; Selda Genisyuerek; Angelika Harneit; Jürgen R. Schwarz; Andreas H. Guse

TRPM4b is a Ca2+‐activated, voltage‐dependent monovalent cation channel that has been shown to act as a negative regulator of Ca2+ entry and to be involved in the generation of oscillations of Ca2+ influx in Jurkat T‐lymphocytes. Transient overexpression of TRPM4b as an enhanced green fluorescence fusion protein in human embryonic kidney (HEK) cells resulted in its localization in the plasma membrane, as demonstrated by confocal fluorescence microscopy. The functionality and plasma membrane localization of overexpressed TRPM4b was confirmed by induction of Ca2+‐dependent inward and outward currents in whole cell patch clamp recordings. HEK‐293 cells stably overexpressing TRPM4b showed higher ionomycin‐activated Ca2+ influx than wild‐type cells. In addition, analysis of the membrane potential using the potentiometric dye bis‐(1,3‐dibutylbarbituric acid)‐trimethine oxonol and by current clamp experiments in the perforated patch configuration revealed a faster initial depolarization after activation of Ca2+ entry with ionomycin. Furthermore, TRPM4b expression facilitated repolarization and thereby enhanced sustained Ca2+ influx. In conclusion, in cells with a small negative membrane potential, such as HEK‐293 cells, TRPM4b acts as a positive regulator of Ca2+ entry.


Traffic | 2015

Lrp1/LDL receptor play critical roles in mannose 6-phosphate-independent lysosomal enzyme targeting

Sandra Markmann; Melanie Thelen; Kerstin Cornils; Michaela Schweizer; Nahal Brocke-Ahmadinejad; Thomas E. Willnow; Joerg Heeren; Volkmar Gieselmann; Thomas Braulke; Katrin Kollmann

Most lysosomal enzymes require mannose 6‐phosphate (M6P) residues for efficient receptor‐mediated lysosomal targeting. Although the lack of M6P residues results in missorting and hypersecretion, selected lysosomal enzymes reach normal levels in lysosomes of various cell types, suggesting the existence of M6P‐independent transport routes. Here, we quantify the lysosomal proteome in M6P‐deficient mouse fibroblasts (PTki) using Stable Isotope Labeling by Amino acids in Cell culture (SILAC)‐based comparative mass spectrometry, and find unchanged amounts of 20% of lysosomal enzymes, including cathepsins D and B (Ctsd and Ctsb). Examination of fibroblasts from a new mouse line lacking both M6P and sortilin, a candidate for M6P‐independent transport of lysosomal enzymes, revealed that sortilin does not act as cargo receptor for Ctsb and Ctsd. Using fibroblast lines deficient for endocytic lipoprotein receptors, we could demonstrate that both LDL receptor and Lrp1 mediate the internalization of non‐phosphorylated Ctsb and Ctsd. Furthermore, the presence of Lrp1 inhibitor increased the secretion of Ctsd from PTki cells. These findings establish Lrp1 and LDL receptors in M6P‐independent secretion‐recapture targeting mechanism for lysosomal enzymes.


Molecular Oncology | 2014

Inhibition of PARP1‐dependent end‐joining contributes to Olaparib‐mediated radiosensitization in tumor cells

Annika Kötter; Kerstin Cornils; Kerstin Borgmann; Jochen Dahm-Daphi; Cordula Petersen; Ekkehard Dikomey; Wael Y. Mansour

Poly‐ADP‐ribose‐polymerase inhibitors (PARPi) are considered to be optimal tools for specifically enhancing radiosensitivity. This effect has been shown to be replication‐dependent and more profound in HR‐deficient tumors. Here, we present a new mode of PARPi‐mediated radiosensitization which was observed in four out of six HR‐proficient tumor cell lines (responders) investigated, but not in normal cells. This effect is replication‐independent, as the radiosensitization remained unaffected following the inhibition of replication using aphidicolin. We showed that responders are radiosensitized by Olaparib because their DSB‐repair is switched to PARP1‐dependent end‐joining (PARP1‐EJ), as evident by (i) the significant increase in the number of residual γH2AX foci following irradiation with 3Gy and treatment with Olaparib, (ii) the enhanced enrichment of PARP1 at the chromatin after 3Gy and (iii) the inhibition of end‐joining activity measured by a specific reporter substrate upon Olaparib treatment. This is the first study which directly demonstrates the switch to PARP1‐EJ in tumor cells and its contribution to the response to Olaparib as a radiosensitizer, findings which could widen the scope of application of PARPi in tumor therapy.

Collaboration


Dive into the Kerstin Cornils's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lars Thielecke

Dresden University of Technology

View shared research outputs
Top Co-Authors

Avatar

Ingmar Glauche

Dresden University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ingo Roeder

Dresden University of Technology

View shared research outputs
Top Co-Authors

Avatar

Andreas Dahl

Dresden University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zhixiong Li

Hannover Medical School

View shared research outputs
Researchain Logo
Decentralizing Knowledge